Skip to content

Evaluation of the clinical efficacy and the effect on the expression of neuropeptides by using Qinggan Liangxue Jiedu decoction in patients with psoriasis blood heat syndrome.

Evaluation of the clinical efficacy and the effect on the expression of neuropeptides by using Qinggan LiangxueJiedu decoction in patients with Psoriasis blood heat syndrome.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016093
Enrollment
Unknown
Registered
2018-05-10
Start date
2018-05-11
Completion date
Unknown
Last updated
2018-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psoriasis

Interventions

1:oral Qinggan Liangxue Jiedu decoction
2:oral Liangxue Jiedu decoction

Sponsors

Beijing Institute of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Meet the Western diagnostic criteria for psoriasis vulgaris; 2. Meet psoriasis blood heat syndrome differentiation criteria; 3. The condition is mild and moderate, and the skin lesion area is less than 30% of the body surface area; 4. The ill in the processing; 5. Age 18 to 60 years old; 6. Signed informed consent, voluntary test.

Exclusion criteria

Exclusion criteria: 1. Oral administration of glucocorticoids and/or immunosuppressives, and retinoids or glucocorticoid preparations for two weeks or more, retinoids and vitamin D3 derivatives in recent months; 2. Women during pregnancy, pregnancy or lactation; 3. Combined with cardiovascular, liver, kidney and hematopoietic system, severe primary diseases and mental illness; 4. People who are allergic to our drugs; 5. Patients who are participating in other clinical trials.

Design outcomes

Secondary

MeasureTime frame
neuropeptide;HAMA score;The recurrence rate;TCM syndrome efficacy score.;

Primary

MeasureTime frame
efficient;

Countries

China

Contacts

Public ContactLi Ping

Beijing Institute of Traditional Chinese Medicine

liping411@126.com+86 010 52176679

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026